Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Vagus Nerve Stimulation in the Developmentally Disabled.

Mary R. Andriola, Susan A. Vitale

Epilepsy & Behavior : E&B

|March 1, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Electroencephalogram in Children with Developmental Dysphasia.

Epilepsy & behavior : E&B·2003

See all related articles

Vagus nerve stimulation (VNS) effectively reduced seizures by over 50% in 68% of developmentally disabled epilepsy patients within 6 months. This therapy was well-tolerated, showing no adverse events preventing chronic use.

Area of Science:

Neurology
Neurosurgery
Epilepsy Research

Background:

Vagus nerve stimulation (VNS) using the neuro cybernetic prosthesis (NCP) is approved for partial seizures in patients 12+. Developmental disabilities present unique challenges for VNS evaluation and management.
Refractory epilepsy in developmentally disabled individuals requires effective and safe treatment options.

Purpose of the Study:

To evaluate the efficacy and tolerability of VNS with NCP in patients with mild to severe mental retardation and epilepsy.
To assess seizure reduction, side effects, behavioral changes, and antiepileptic drug (AED) adjustments in this patient cohort.

Main Methods:

Retrospective chart review of 21 patients (ages 3-56) with mental retardation who received NCP implantation.
Analysis of seizure frequency, adverse events, behavioral observations, and AED regimens pre- and post-VNS implantation.

Related Experiment Videos

Focus on patients with clearly evaluable seizures (n=16) for efficacy assessment at 6 months.

Main Results:

A >50% reduction in seizures was observed in 68% (11/16) of evaluable patients after 6 months of VNS.
No adverse events occurred that precluded chronic VNS therapy.
Institutional staff and families received comprehensive pre- and postoperative education on VNS and magnet use.

Conclusions:

Vagus nerve stimulation (VNS) appears to be an effective and well-tolerated therapeutic option for developmentally disabled patients with refractory epilepsy.
The study supports the use of VNS in this challenging patient population, highlighting the importance of patient and caregiver education.